Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Bullboard - Stock Discussion Forum Bionano Genomics Inc BNGO

Technology Scientific & Technical Instruments

Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform... see more

Add To Watchlist

Bullboard (NDAQ:BNGO)

View:

Post by whytestockson Oct 31, 2024 8:15pm

Bionano Adjourns Special Meeting of Stockholders to November

News; $BNGO Bionano Adjourns Special Meeting of Stockholders to November 27, 2024SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it adjourned ...more

37

Post by PressReleaseon Jan 31, 2024 8:00am

New Press Release - Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference

SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which will take...read article.

Bitcoin-Backed LQWD Technologies Lightning Network Infrastructure Surpasses One Million Global Transactions

posted Nov 21, 2024 9:00am by LQWD Technologies Corp.

Since deploying LQWD's Bitcoin Lightning Network strategy in November 2021, the Company's transaction infrastructure continues to experience strong growth with exponential growth in 2024. From January 1, 2024, to October 31, 2024 LQWD facilitated approximately 643,000 transactions, compared to approximately 112,900 transactions for the same period in 2023. ...read more

Post by PressReleaseon Jan 30, 2024 8:00am

New Press Release - Bionano's Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS

Over 2,100 registrants with attendees from 92 countriesAverage daily attendance of 574 32 oral presentations delivered across four consecutive days69 scientific posters featuring optical genome mapping (OGM) on view in the online exhibit hallContent covered wide a range of research applications...read article.

Post by PressReleaseon Jan 25, 2024 8:00am

New Press Release - Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer

SAN DIEGO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication in Cancers from a team of cancer researchers primarily at the NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute and Scripps MD Anderson in...read article.

Post by PressReleaseon Jan 24, 2024 8:00am

New Press Release - Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing

Pre-print publication from Levy, et al. describes the second phase of a multisite evaluation and validation of optical genome mapping (OGM) that is designed to measure the workflow’s accuracy and clinical utility compared to classical cytogenetic methodsOGM data from 342 unique cases (419...read article.

Post by PressReleaseon Jan 23, 2024 8:00am

New Press Release - Bionano Announces Full Commercial Release of the Stratys(TM) System for High Throughput Optical Genome Mapping

Bionano has completed the early access program for the Stratys™ system and is now making it available in a full commercial release The Stratys instrument can enable up to a four-fold increase in raw data generation rate compared to the Saphyr®instrument and can process up to 12 single access...read article.

Post by PressReleaseon Jan 19, 2024 8:00am

New Press Release - Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications

26 different customers representing North America, Asia and Europe33 oral presentations across four consecutive days69 scientific posters will be featured in a virtual exhibition hallTopics span the application of optical genome mapping (OGM) in research applications in cancer, cell and gene...read article.

Post by PressReleaseon Jan 11, 2024 4:01pm

New Press Release - Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing

Peer-reviewed publication from Broeckel, et al. describes the second phase of a multisite evaluation of optical genome mapping (OGM) in 627 samples (597 unique samples and 30 replicates) Overall, for the entire study, OGM data have been collected from 1,000 samples, including 404 samples from...read article.

Post by PressReleaseon Jan 10, 2024 8:00am

New Press Release - Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications

SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its 2024 Symposium, the quintessential event for the optical genome mapping (OGM) community. The event is an opportunity for OGM users to present their progress to the world. 2024 Symposium will...read article.

Post by PressReleaseon Jan 08, 2024 8:00am

New Press Release - Bionano Reports Preliminary Fourth Quarter and Full-Year 2023 Results

Preliminary Q4 2023 revenue expected to be between $10.4 and $10.7 million, which would represent an estimated increase of 27% to 30% over Q4 2022 Reached installed base of 326 optical genome mapping (OGM) systems as of YE 2023; increase of 36% over the 240 installed systems as of YE...read article.

Post by PressReleaseon Jan 03, 2024 8:00am

New Press Release - International Consortium Publishes Comprehensive Roadmap for the Clinical Implementation of OGM in Hematological Malignancy Applications

Framework was co-authored by an international consortium made up of 18 cancer researchers Publication includes researchers’ recommendations for laboratories planning to adopt optical genome mapping (OGM) on topics including assay development, clinical validation, implementation, algorithms for...read article.

Post by PressReleaseon Jan 03, 2024 8:00am

New Press Release - OGM Added to International System for Human Cytogenomic Nomenclature

SAN DIEGO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced a publication outlining the addition of optical genome mapping (OGM) to the International System for Human Cytogenomic Nomenclature (ISCN). The OGM nomenclature is expected to be published in the...read article.

Post by PressReleaseon Dec 28, 2023 8:00am

New Press Release - Bionano Announces Significant Upgrades to its Bionano Solve Pipeline and its VIA(TM) Software for OGM Data Analysis in Constitutional Genetic Disease Research

SAN DIEGO, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced significant upgrades to its pipeline for analysis of optical genome mapping (OGM) data in its VIA™ software for applications in constitutional genetic disease. The latest analysis pipeline, Bionano...read article.

Post by PressReleaseon Dec 26, 2023 8:00am

New Press Release - Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and Karyotyping

Key findings from prospective evaluation of 200 prenatal samples: Optical genome mapping (OGM) detected pathogenic structural variants (SVs) in 20.5% of samples (41/200); combination of chromosomal microarray analysis (CMA) and karyotyping (KT) detected pathogenic SVs in 19.5% of samples (39...read article.

Post by PressReleaseon Dec 14, 2023 8:00am

New Press Release - Cancers Journal Publishes Special Issue Dedicated to OGM's Impact on Hematological Malignancy Research

SAN DIEGO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a special issue of Cancers journal entirely dedicated to the Company’s optical genome mapping (OGM) workflow. The issue, which features guest editors Dr. Adam Smith from...read article.

The Market Update

{{currentVideo.title}} {{currentVideo.relativeTime}}

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}

{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous

{{moreVideoText}}

Next >

Dealroom for high-potential pre-IPO opportunities

Featured News Links

Discover Options Trading Strategies to Minimize your Tax Burden